Published trade mark details for 2483504
This information was published on 2025-02-19T00:08:38 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2483504 |
| (220) |
18 Sep 2024
|
| (511) (510) |
Class 5
Pharmaceutical preparations; pharmaceutical products; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for oncology; pharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung cancer; pharmaceutical preparations for the treatment of colorectal cancer; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceutical preparations containing low molecular weight compounds; pharmaceutical preparations containing small molecules for the treatment of cancer; pharmaceutical preparations containing low molecular weight compounds for the treatment of infectious diseases; pharmaceutical preparations containing small molecules for the treatment of lung cancer; pharmaceutical preparations containing small molecules for the treatment of non-small cell lung cancer; pharmaceuticals with low molecular weight compounds for the treatment of colorectal cancer; pharmaceutical preparations containing small molecules for the treatment of pancreatic cancer; pharmaceutical drug compounds; pharmaceutical drug compounds for the treatment of cancer; pharmaceutical preparations containing inhibitors; pharmaceutical preparations containing inhibitors for the treatment of cancer; pharmaceutical preparations for the treatment of solid tumors; pharmaceutical preparations for the treatment of advanced solid tumors. Class 42 Research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; pharmaceutical research and development; providing information in the field of scientific and medical research relating to pharmaceuticals. |
| (540) |
|
| (550) | Figurative |
| (730) |
Mirati Therapeutics, Inc.
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.